Page last updated: 2024-10-25

chlorpromazine and Corneal Dystrophies

chlorpromazine has been researched along with Corneal Dystrophies in 1 studies

Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sahyoun, JY1
Sabeti, S1
Robert, MC1

Reviews

1 review available for chlorpromazine and Corneal Dystrophies

ArticleYear
Drug-induced corneal deposits: an up-to-date review.
    BMJ open ophthalmology, 2022, Volume: 7, Issue:1

    Topics: Chlorpromazine; Corneal Dystrophies, Hereditary; Corneal Opacity; Humans; Rifabutin; Vision Disorder

2022